Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 26, 2023

BUY
$1.63 - $3.52 $236 - $510
145 Added 8.0%
1,957 $0
Q2 2022

Aug 19, 2022

BUY
$2.2 - $4.2 $3,986 - $7,610
1,812 New
1,812 $4.31 Million
Q1 2022

May 11, 2022

SELL
$2.83 - $8.69 $2,555 - $7,847
-903 Closed
0 $0
Q4 2021

Jan 21, 2022

BUY
$8.31 - $14.92 $3,290 - $5,908
396 Added 78.11%
903 $8,000
Q3 2021

Nov 12, 2021

BUY
$9.15 - $13.28 $4,639 - $6,732
507 New
507 $8,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $10.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Eagle Bay Advisors LLC Portfolio

Follow Eagle Bay Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.